Patents by Inventor NATHALIA APARECIDA DE PAULA CAMAFORTE HENRIQUES

NATHALIA APARECIDA DE PAULA CAMAFORTE HENRIQUES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of cyanoglucosides and pharmaceutical formulations thereof in the treatment of diabetes
    Patent number: 11179408
    Abstract: The present invention relates to the use of cyanoglucoside according to formula (I) and formulations thereof in the prevention and/or treatment of diabetes and/or metabolic syndrome; wherein R1, R2 and R3 are independently selected from an optionally substituted mono- or di-saccharide, —O—R4, —O—C(O)—R4 and halogen, such as Cl, F or Br, wherein R4 is selected from H, alkyl, such as methyl, as well as tautomers, geometrical isomers, optically active forms, pharmaceutically acceptable salts and pharmaceutically active derivative thereof.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: November 23, 2021
    Assignees: UNIVERSITÉ DE GENÈVE, UNIVERSIDADE ESTADUAL PAULISTA JÚLIO DE MESQUITA FILHO
    Inventors: Luiz Leonardo Saldanha, Anne Ligia Dokkedal Bosqueiro, Jose Roberto Bosqueiro, Nathalia Aparecida De Paula Camaforte Henriques, Priscilla Maria Ponce Vareda, Wagner Vilegas, Emerson Ferreira Queiroz, Laurence Marcourt, Jean-Luc Wolfender
  • USE OF CYANOGLUCOSIDES AND PHARMACEUTICAL FORMULATIONS THEREOF IN THE TREATMENT OF DIABETES
    Publication number: 20190160085
    Abstract: The present invention relates to the use of cyanoglucoside according to formula (I) and formulations thereof in the prevention and/or treatment of diabetes and/or metabolic syndrome; wherein R1, R2 and R3 are independently selected from an optionally substituted mono- or di-saccharide, —O—C(O)—R4 and halogen, such as Cl, F or Br, wherein R4 is selected from H, alkyl, such as methyl, as well as tautomers, geometrical isomers, optically active forms, pharmaceutically acceptable salts and pharmaceutically active derivative thereof.
    Type: Application
    Filed: June 28, 2016
    Publication date: May 30, 2019
    Applicants: UNIVERSIDADE ESTADUAL PAULISTA JULIO DE MESQUITA FILHO, UNIVERSITE DE GENEVE
    Inventors: LUIZ LEONARDO SALDANHA, ANNE LIGIA DOKKEDAL BOSQUEIRO, JOSE ROBERTO BOSQUEIRO, NATHALIA APARECIDA DE PAULA CAMAFORTE HENRIQUES, PRISCILLA MARIA PONCE VAREDA, WAGNER VILEGAS, EMERSON FERREIRA QUEIROZ, LAURENCE MARCOURT, JEAN-LUC WOLFENDER